OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients

Marcin Kowanetz, Wei Zou, David S. Shames et al. · Journal of Thoracic Oncology · 2017

Cited by 86 works. doi:10.1016/j.jtho.2016.11.343 Open-access PDF

Authors